Terminalia arjuna (Roxb.) wt. and am.: A review

International Journal of Pharmacology

Volumn 6, Issue 5, 2010, Pages 515-534

  Paarakh, Padmaa M ^a  

^a Oxford College of Pharmacy   (India)

Author keywords

Arjuna; Bark; Combretaceae; Medicinal plant; Pharmacognosy; Pharmacology; Phytochemistry; Review; Terminalia arjuna

Indexed keywords

ALPHA TOCOPHEROL; APIGENIN; ARJUNAPHTHANOLOSIDE; ARJUNETIN; ARJUNGENIN; ARJUNIC ACID; ARJUNOGLUCOSIDE; ARJUNOLIC ACID; ARJUNOLITIN; ARJUNORE; ARJUNOSIDE III; CAPS HT2; CASUARININ; CYANIDIN; ELLAGIC ACID; ISOSORBIDE MONONITRATE; KAEMPFEROL; LIPISTAT; LIV 52; LUTEOLIN; MORPHINE; PELARGONIDIN; PLACEBO; PLANT MEDICINAL PRODUCT; QUERCETIN; TERMINALIA ARJUNA EXTRACT; TERMINIC ACID; TERMINOIC ACID; TERMINOSIDE A; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; ANALGESIC ACTIVITY; ANEMIA; ANGINA PECTORIS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ASTHMA; ATHEROSCLEROSIS; AYURVEDA; BARK; BLEEDING; BRONCHITIS; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COUGHING; DIABETES MELLITUS; DIARRHEA; DRUG CYTOTOXICITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG INDICATION; DRUG ISOLATION; DRUG SAFETY; DRUG STRUCTURE; DYSENTERY; EVENING DOSAGE; FATIGUE; FLOWER; FRACTURE; FRUIT; HEART DISEASE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HEMATOLOGICAL PARAMETERS; HEPATOBILIARY PARAMETERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOMODULATION; INDIA; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKORRHEA; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER PROTECTION; LYMPHOMA; MEDICINAL PLANT; MITRAL VALVE REGURGITATION; MORNING DOSAGE; NONHUMAN; OTALGIA; OXIDATIVE STRESS; PAIN; PAW EDEMA; PHARMACOGNOSY; PHYTOCHEMISTRY; PLANT GROWTH; PLANT LEAF; PLANT MORPHOLOGY; REPERFUSION INJURY; REPRODUCTION; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DISEASE; STABLE ANGINA PECTORIS; STOMACH PROTECTION; STOMACH ULCER; SWEAT GLAND DISEASE; TESTIS INJURY; THORAX PAIN; TUMOR; ULCER; UROGENITAL SYSTEM PARAMETERS; WOUND; WOUND HEALING;

EID: 77955700389     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.515.534     Document Type: Review

References (118)

1. Ahmad, M.U., K.B. Mullah, T. Norm and J.K. Ulla, 1983. Terminoic acid, a new trihydroxytriterpene carboxylic acid from bark of Terminalia arjuna. Indian J. Chem., 22: 738-740.
2. Alam, M.S., G. Kaur, A. Ah, H. Hamid, M. AH and M. Athar, 2008. Two new bioactive oleanane triterpene glycosides from Terminalia arjuna. Natl. Prod. Res., 22: 1279-1288.
3. Ah, A., G. Kaur, K. Hayat, M. Ah and M. Ather, 2003a. A novel naphthanol glycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie, 58: 932-934.
4. Ah, A., G. Kaur, H. Hamid, T. Abdullah, M. Ah, M. Niwa and M.S. Alam, 2003b. Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J. Asian Natl. Prod. Res., 5: 137-142.
5. Ah, M., 1994. Text Book of Pharmacognosy. CBS Publishers, New Delhi.
6. Anand, V., 1994. Antianginal andcardio protective effects of Terminalia arjuna. J. Assoc. Physicians India, 42: 757-758.
7. Anjaneyulu, A.S.R. and A.V. Rama-Prasad, 1982a. Chemical examination of the roots of Terminalia ar/wHa-characterization of two new triterpenoid glycoside. Indian J. Chem., 21: 530-533.
8. Anjaneyulu, A.S.R. and A.V. Rama-Prasad, 1982b. Structure of terminic acid, a dihyroxy triterpene carboxylic acid from Terminalia arjuna. Phytochemistry, 21: 2057-2060.
9. Anj aneyulu, A.S.R. and A.V. Rama-Prasad., 1983. Chemical examination of the roots of Terminalia arjuna- the structure of arjunoside III and IV, two new triterpenoid glycoside. Phytochemistry, 22: 993-998.
10. Anonymous, 1976. The Wealth of India: A Dictionary of Indian Raw Materials. Vol. 60, CSIR, New Delhi.
11. Anonymous, 1999. The Ayurvedic Pharmacopoeia of India. Part 1, Ministry of Health and Family Welfare, New Delhi.
12. Anonymous, 2005. Quality Standards of Indian Medicinal Plants. Ministry of Health and Family Welfare, New Delhi.
13. Arora, R.C., N. Agarwal, S. Aroraand, SN. Kanchan, 1995. Evaluation of CTI in subjects of coronary artery disease, hypertension and diabetes mellitus. Flora Fauna, 1: 203-205.
14. Atal, C.K. and B.M. Kapur, 1982. Cultivation and Utilization of Medicinal Plants. Regional Research Laboratory, CSIR, Jammu-Tawi.
15. Bharani, A., A. Ganguly and K.D. Bhargava, 1995. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure. Int. J. Cardiol., 49: 191-199.
16. Bharani, A., A. Ganguli, L.K. Mathur, Y. Jamra and P.G. Raman, 2002. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebocontrolled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J., 54: 170-175.
17. Chaudhari, M. and S. Mengi, 2006. Evaluation of phytoconstituents of Terminalia arjuna for wound healing activity in rats. Phytother. Res., 20: 799-805.
18. Chen, C.H., T.Z. Liu, T.C. Kuo, F.J. Lu, Y.C. Chen, Y.W. Chang-Chien and C.C. Lin, 2004. Casuarmm protects cultured MDCK cells from hydrogen peroxide-induced oxidative stress and DNA oxidative damage. PlantaMed., 70: 1022-1026.
19. Cheng, H.Y., C.C. Lin and T.C. Lin, 2002. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antivir. Res., 55: 447-455.
20. Chitlange, S.S., P.S. Kulkarm, D. Patil, B. Patwardhan and R.K. Nanda, 2009. High-performance liquid chromatographic fingerprint for quality control of Terminalia arjuna containing Ayurvedic churna formulation. J. AOAC. Int., 92: 1016-1020.
21. Chopra, R.N., I.C. Chopra, K.L. Handa and L.D. Kapur, 1958. Chopra's Indigenous Drugs of India. Dhur and Sons Private Ltd., Calcutta.
22. Cooke, T., 1967. The Flora of Presidency of Bombay. Vol. 1. Botanical Survey of India, Calcutta.
23. Devi, R.S., S. Narayan, G. Vani and C.S. Shyamala-Devi, 2007a. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chem. Biol. Interact, 167: 71-83.
24. Devi, R.S., S. Narayan, G. Vani, P. Srinivasan, K.V. Mohan, K.E. Sabitha and C.S. Devi, 2007b. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytother. Res., 21: 762-767.
25. Devi, R.S., M. Kist, G. Vani and C.S. Devi, 2008. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharideinduced gastric ulcer in rats. J. Pharmer Pharmacol., 60: 505-514.
26. Dwivedi, S. and N. Udupa, 1989. Terminalia arjuna: Pharmacognosy, phytochemistry, pharmacology and clinical use: A review. Fitoterapia, 60: 413-420.
27. Dwivedi, S. and M.P. Agarwal, 1994. Antianginal and cardio protective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J. Assoc. Physicians India, 42: 287-289.
28. Dwived, I S and R. Jauhari, 1997. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J., 49: 507-510.
29. Dwivedi, S., A. Agarwal, M.P. Agarwal and S. Rajpal, 2005. Role of Terminalia arjuna in ischemic mitral regurgitation. Int. J. Cardiol., 100: 507-508.
30. Gauthaman, K., S.K. Banerjee, A.K. Dinda, C.C. Ghosh and S.K. Maulik, 2005. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock protein. J. Ethnopharmacol., 96: 403-409.
31. Gupta, D.P., 1998. The Herb, Habitat, Morphology and Pharmacognosy of Medicinal Plant. Printwell Offset Publisher, Madhya Pradesh.
32. Gupta, R., S. Singhal, A. Guyle and V.N. Sharma, 2001. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: A randomized placebo-controlled trial. J. Assoc. Physicians India, 49: 231-235.
33. Haider, S., N. Bharal, P.K. Mediratta, I. Kaur and K.K. Sharma, 2009. Anti-inflammatory, immunomodulatory and antinociceptive activity of Terminalia arjuna Roxb bark powder in mice and rats. Indian J. Exp. Biol, 47: 577-583.
34. Handa, S.S. and M.K. Kaul, 1996. Supplement to Cultivation and Utilization of Medicinal Plants. In: RRL, Handa, S.S. and M.K. Kaul (Eds.). CSIR Publication, Jammu Tawi, pp: 334-348.
35. Huseini, F., S.M. Alavian, R. Heshmat, M.R. Heydari and K. Abolmaali, 2005. The efficacy of Liv-52 on liver cirrhotic patients: A randomized, double-blind, placebo-controlled first approach. Phytomedicine, 12: 619-624.
36. Kandil, F.E. and M.I. Nassar, 1998. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry, 47: 1567-1568.
37. Karthikeyan, K., B.R. Sarala Bai, K. Gauthaman, K.S. Sathish and S. Niranjali Devaraj, 2003. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. J. Life Sci., 73: 2727-2739.
38. Kaur, S., I.S. Grover and S. Kumar, 1997. Antimutagenic potential of ellagic acid isolated from Terminalia arjuna. Indian J. Exp. Biol., 35: 478-482.
39. Kaur, ST., I S. Grover and S. Kumar, 2000. Modulatory effects of a tannin fraction isolated from Terminalia arjuna on the genotoxicity of mutagens in Salmonella typhimurium. Food Chem. Toxicol., 38: 1113-1119.
40. Kaur, S., I S. Grover and S. Kumar, 2001. Antimutagenic potential of extracts isolated from Terminalia arjuna. J. Environ. Patho. Toxicol. Oncol, 20: 9-14.
41. Kaur, K., S. Arora, S. Kumar and A. Nagpal, 2002a. Modulatory effect of phenolic fractions of Terminalia arjuna on the mutagenicity in Ames assay. J. Environ. Pathol. Toxicol. Oncol., 21: 45-56.
42. Kaur, K., S. Arora, S. Kumar and A. Nagpala, 2002b. Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna. Food Chem. Toxicol., 40: 1475-1482.
43. Khan, M.T., I. Lampronti, D. Martello, N. Bianchi and S. Jabbar et al, 2002. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: Effects on in vitro cell growth of human tumor cell lines. Int. J. Oncol., 21: 187-192.
44. Khan, R., B. Islam, M. Akram, S. Shakil and A. Ahmadx et-al, 2009. Antimicrobial activity of five herbal extracts against Multi Drug Resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules, 14: 586-597.
45. Kirtikar, K.R and B.D. Basu, 1989. Indian Medicinal Plants. L M Basu Publication, Allahabad.
46. Kumar, D.S. and Y.S. Prabhakar, 1987. On the ethnomedical significance of the Arjuna tree Terminalia arjuna. J. Ethnopharmacol., 20: 173-190.
47. Kumar, P.U., P. Adhikari, P. Pereira and P. Bhat, 1999. Safety and efficacy of Hartone in stable angina pectoris-an open comparative trial. J. Assoc. Physicians India, 47: 685-689.
48. Kumar, S., R. Enjamoori, A. Jaiswal, R. Ray, S. Seth and S.K. Maulik, 2009. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J. Pharm. Pharmacol., 61: 1529-1536.
49. Kumari, N, 1998. Induction of somatic embryogenesis and plant regeneration from leaf callus of Terminalia arjuna. Curr. Sci., 75: 1052-1055.
50. Kuo, PL., Y.L. Hsu, T.C. Lin, L.T. Lm, J.K. Chang and C.C. Lin, 2005a. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7 cells. PlantaMed., 71: 237-243.
51. Kuo, PL., Y.L. Hsu, T.C. Lin, L.T. Lin, J.K. Chang and C.C. Lin, 2005b. Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn. Anticancer Drugs, 16: 409-415.
52. Malik, N, V. Dhawan, A. Bahl and D. Kaul, 2009. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease. Platelets, 20: 183-190.
53. Manna, P., M. Sinhaand, P.C. Sil, 2006. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complementary Alternative Med., 6: 33-33.
54. Manna, P., M. Sinha and P.C. Sil, 2007a. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology, 14: 71-78.
55. Manna, P., M. Sinha, P. Pal and P.C. Sil, 2007b. Arjunolic acid, a triterpenoid saponin, ameliorates arsenicinduced cyto-toxicity in hepatocytes. Chemico Biol. Interact, 170: 187-200.
56. Manna, P., M. Sinha and P.C. Sil, 2008. Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Rep., 13: 67-77.
57. Mary, N.K., B.H. Babu and J. Padikkala, 2003. Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation. Phytomedicine, 10: 474-482.
58. Mitra, R., 1985. Bibliography on Pharmacognosy of Medicinal Plants. NBRI, Lucknow.
59. Mukherjee, P.K., K. Mukherjee, M. Rajesh Kumar, M. Pal and B.P. Saha, 2003. Evaluation of wound healing activity of some herbal formulations. Phytother. Res., 17: 265-268.
60. Munasinghe, T.C, C.K. Seneviratne, M.I. Thabrew and A.M. Abeysekera, 2001. Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. J. Phytother. Res., 15: 519-523.
61. Nadkarni, A.K., 1976. Indian Materia Medica. 1st Edn., Popular Prakashan, Mumbai, India.
62. Nagpal, A., L.S. Meena, S. Kaur, I S. Grover, R. Wadhwa and S.C. Kaul, 2000. Growth suppression of human transformed cells by treatment with bark extracts from a medicinal plant, Terminalia arjuna. In vitro Cell Dev. Biol. Anim., 36: 544-547.
63. Nammi, S., R. Gudavalli, B.S. Babu, D.S. Lodagala and K.M. Boini, 2003. Possible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs. BMC Complement Altern. Med., 3: 5-5.
64. Padmaa, M.P., J.P. Leena and S.T. Angelin, 2008. Genius Salacia: A comprehensive review. J. Natural Remedies, 8: 116-131.
65. Padmaa, M.P., 2009a. Coriandrum sativum Linn: A review. Pharmacologyonline Newsletter, 3: 561-573.
66. Padmaa, M.P., 2009b. Ficus racemosa Linn.: A overview. Natural Product Radiance, 8: 84-91.
67. Padmaa, M.P., 2009c. A phyto-pharmacological review of Gmelina arborea Roxb. Herbal Heritage, 1: 8-17.
68. Padmaa, M.P., 2009d. Phytoconstituents fom the genus Petunia: A review. Pharmacologyonline Newsletter, 1: 195-208.
69. Pandey, S. and V.S. Jaiswal, 2002. Micropropagation of Terminalia arjuna Roxb. from cotyledonary nodes. Indian J. Exp. Biol., 40: 950-953.
70. Parmar, H.S., S. Panda, R. Jatwa and A. Kar, 2006. Cardioprotective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie, 61: 793-795.
71. Pasquini, R, G. Scassellati-Sforzolini, M. Villarini, M. Moretti and M. Marcarelli et al, 2002. In vitro protective effects of Terminalia arjuna bark extracts against the 4-nitroquinoline-N-oxide genotoxicity. J. Environ. Pathol. Toxicol. Oncol., 21: 33-44.
72. Pawar, R.S. and K.K. Bhutam, 2005. Effect of oleanane triterpenoids from Terminalia arjuna-a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine, 12: 391-393.
73. Perumal Samy, R., S. Ignacimuthu and H. Sen, 1998. Screening of 34 Indian medicinal plants for antibacterial properties. J. Ethnopharmacol., 62: 173-182.
74. Pettit, G.R., M.S. Hoard, D.L. Doubek, J.M. Schmidt, R.K. Pettit, L.P. Tackett and 1996. Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J. Ethnopharmacol., 53: 57-63.
75. Raghavan, B. and S.K. Kumari, 2006. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats. Indian J. Physiol. Pharmacol., 50: 133-142.
76. Raghunathan, K. and M.K. Mitra, 1982. Pharmacognosy of Indigenous Drugs. Vol. 1, Central Council for Research in Ayurveda and Siddha, New Delhi, pp: 127-139.
77. Ram, A., P. Lauria, R. Gupta, P. Kumar and V.N. Sharma, 1997. Hypocholesterolaemic effects of Terminalia arjuna tree bark. J. Ethnopharmacol., 55: 165-169.
78. Ramesh, C, S. Kavita, A.K. Khanna, S.M. Kaul, P. Anju and S. Rashmi, 2004. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock protein. J. Ethnopharmacol., 96: 403-409.
79. Rane, M.M. and S.A. Mengi, 2003. Comparative effect of oral administration and topical application of alcoholic extract of Terminalia arjuna bark on incision and excision wounds in rats. Fitoterapia, 74: 553-558.
80. Rani, P. and N. Khullar, 2004. Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi. Phytother. Res., 18: 670-673.
81. Rastogi, R.P. and B.N. Mehrotra, 1993a. Compendium of Indian Medicinal Plants. Vol. 1, CSIR, New Delhi.
82. Rastogi, R.P. and B.N. Mehrotra, 1993b. Compendium of Indian Medicinal Plants. Vol. 2, CSIR, New Delhi.
83. Rastogi, R.P. and B.N. Mehrotra, 1993c. Compendium of Indian Medicinal Plants. Vol. 3, CSIR, New Delhi.
84. Reddy, T.K., P. Seshadri, K.K. Reddy, G.C. Jagetia and CD. Reddy, 2008. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage. Phytother. Res., 22: 1188-1194.
85. Row, L.R., P.S. Murty, G.S.R. Subba-Rao, C.S.P. Sastry and K.V.J. Rao, 1970a. Chemical examination of Terminalia arjuna: Part-XII: Isolation and structure determination of arjunetin from Terminalia arjuna bark. Indian J. Chem., 8: 772-775.
86. Row, L.R., P.S. Murty, G.S.R. SubbaRao, C.S.P. Sastry and K.V.J. Rao, 1970b. Chemical examination of Terminalia arjuna: Part-XII: Isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Indian J. Chem., 8: 716-721.
87. Sahm, K.P. and M.P. Padmaa, 2009. A phytopharmacological review of Syzygium cumini skeels. Pharmacologyonline Newsletter, 2: 110-122.
88. Sandeep and M.P. Padmaa, 2009. Jasminum grandiflorum SLinn. (Chameli): Ethnobotany, phytochemistry and pharmacology: A review. Pharmacologyonline Newsletter, 2: 586-595.
89. Sarin, Y.K., 1996. Illustrated manual of Herbal drugs used in Ayurveda National Institute of Science Communication. CSIR, New Delhi, India,.
90. Saxena, M., U. Faridi, R. Mishra, M.M. Gupta and M.P. Darokar et al, 2007. Cytotoxic agents from Terminalia arjuna. Planta Med., 73: 1486-1490.
91. Scassellati-Sforzolini, G., L.M. Villarini, L.M. Moretti, L.M. Marcarelli and R. Pasquini et al, 1999. Antigenotoxic properties of Terminalia arjuna bark extracts. J. Environ. Pathol. Toxicol. Oncol., 18: 119-125.
92. Seth, S.D., M. Maulik, C.K. Katiyar and S.K. Maulik, 1998. Role of Lipistat in protection against isoproterenol induced myocardial necrosis in rats: A biochemical and histopathological study. Indian J. Physiol. Pharmacol., 42: 101-106.
93. Shailaa, H.P., S.L. Udupa and A.L. Udupa, 1998. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int. J. Cardiol, 67: 119-124.
94. Sharma, P.C, M.B. Yelne and T.J. Dennis, 2005. Database on Medicinal Plants used in Ayurveda. CCRAS, New Delhi.
95. Sharma, P.N., A. Shoeb, R.S. Kapil and S.P. Poph, 1982. Arjunolone: A new flavone from stem bark of Terminalia arjuna. Indian J. Chem., 21B: 263-264.
96. Sharma, P.V., 1996. Classical Uses of Medicinal Plants. Chaukhambha Visvabharati, Varanasi, India.
97. Shmde, S.L., S.B. Junne, S.S. Wadje and M.M.V. Baig, 2009. The diversity of antibacterial compounds of Terminalia species (Combretaceae). Pak. J. Biol. Sciences, 12: 1483-1486.
98. Singh, N., K.K. Kapur, S.P. Singh, K. Shanker, J.N. Sinha and R.P. Kohli, 1982. Mechanism of cardiovascular action of Terminalia arjuna. Planta Med., 45: 102-104.
99. Singh, B., V.P. Singh, V.B. Pandey and G. Rucker, 1995. A new triterpene glycoside from Terminalia arjuna. Planta Med., 61: 576-577.
100. Singh, D.V., R.K. Verma, M.M. Gupta and S. Kumar, 2002a. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem. Anal, 13: 207-210.
101. Singh, D.V., R.K. Verma, S.C Singh and M.M. Gupta, 2002b. RP-LC determination of oleane derivatives in Terminalia arjuna. J. Pharm. Biomed. Anal, 28: 447-452.
102. Singh, G., A.T. Singh, A. Abraham, B. Bhat and A. Mukherjee et al, 2008. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J. Ethnopharmacol, 117: 123-129.
103. Sinha, M., P. Manna and P.C. Sil, 2008. Terminalia arjuna protects mouse hearts against sodium fluorideinduced oxidative stress. J. Med. Food., 11: 733-740.
104. Sivalokanathan, S., M. Ilayaraja and M.P. Balasubramanian, 2005. Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Indian J. Exp. Biol, 43: 264-267.
105. Sivalokanathan, S., M. Ilayaraja and M.P. Balasubramanian, 2006a. Antioxidant activity of Terminalia arjuna bark extract on Nnitrosodiethylamine induced hepatocellular carcinoma in rats. Mol. Cell Biochem., 281: 87-93.
106. Sivalokanathan, S., M.R. Vijayababu and M.P. Balasubramanian, 2006b. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J. Gastroenterol, 12: 1018-1024.
107. Sumitra, M., P. Manikandan, D.A. Kumar, A. Natarajan, K. Balakrishna, B.M. Manohar and R. Puvanakrishnan, 2001. Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol. Cell. Biochem., 277: 135-142.
108. Sun, F.Y., X.P. Chen, J.H. Wang, H.L. Qui, S.R. Yang and G.H. Du, 2008. Arjunic acid, a strong free radical scavenger from Terminalia arjuna. Am. J. Chin. Med., 36: 197-207.
109. Tiipathi, V.K., V.B. PAndey, K.N. Udupa and G. Rucker, 1992. Arjunolitin, atriterpene glycoside from Terminalia arjuna. Phytochemistry, 31: 349-351.
110. Tnpathi, Y.B., M.M. Reddy, R.S. Pandey, J. Subhashmi, O.P. Tiwan, B.K. Singh and P. Reddanna, 2004. Antiinflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis. Inflammopharmacology, 12: 131-152.
111. Upadhyay, R.K., M.B. Pandey, R.N. Jha, V.P. Singh and V.B. Pandey, 2001. Triterpene glycoside from Terminalia arjuna. J. Asian Natl. Prod. Res., 3: 207-212.
112. Verma, N. and M. Vinayak, 2009. Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol. Biol. Rep., 36: 159-164.
113. Wang, W., Z. Ah, X.C. Li, Y. Shen and LA. Khan, 2010a. 18, 19-secooleanane type triterpene glycosyl esters from the bark of Terminalia arjuna. Planta Med., Jan. 28 [Epub ahead of print].
114. Wang, W., Z. Ah, X.C. Li, Y. Shen and LA. Khan, 2010b. Triterpenoids from two Terminalia species. Planta Med., Apr. 9 [Epub ahead of print].
115. Wang, W., Z. Ah, X.C. Li, Y. Shen and LA. Khan, 2010c. Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia, Jan. 15 [Epub ahead of print].
116. Warner, P.K., V.P.K. Nambiar and C. Ramankutty, 1994. Indian Medicinal Plants. A Compendium of 500 Species. Vol. 1, Orient Longman Pvt. Ltd., Madras, India.
117. Yadav, R.N. and K. Rathore, 2000. A new cardenolide from the seeds of Terminalia arjuna. J. Asian Natl. Prod. Res., 2: 97-101.
118. Yadav, R.N. and K. Rathore, 2001. A new cardenolide from the roots of Terminalia arjuna. Fitoterapia, 72: 459-461.